Cingulate (CING) Income from Continuing Operations (2021 - 2026)
Cingulate's (CING) quarterly Income from Continuing Operations came in at -$4.6 million in Q2 2026, down 17.74% on a YoY basis from -$5.6 million in Q2 2025, and up 6.39% quarter-over-quarter from -$5.0 million in Q4 2025.
Powered by 
Analysis
Cingulate (CING) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Cingulate (CING) has reported Income from Continuing Operations for 6 consecutive years, with -$4.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations fell 17.74% year-over-year to -$4.6 million; the trailing twelve-month figure through Jun 2026 stood at -$19.3 million (down 27.8% YoY), and the FY2025 full-year result was -$17.7 million, down 35.57% from the prior year.
- Income from Continuing Operations grew to -$4.6 million in Q2 2026 per CING's latest filing, from -$5.0 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at -$2.4 million in Q1 2024 and bottomed at -$5.8 million in Q3 2025.
- Historically, Income from Continuing Operations has averaged -$4.0 million across 5 years, with a median of -$3.9 million in 2025.
- The widest YoY moves for Income from Continuing Operations: up 79.19% in 2022, down 197.16% in 2022.
- Over 5 years, Income from Continuing Operations stood at -$3.6 million in 2022, then tumbled by 51.22% to -$5.5 million in 2023, then grew by 10.24% to -$4.9 million in 2024, then slipped by 0.64% to -$5.0 million in 2025, then rose by 6.39% to -$4.6 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered -$4.6 million, -$5.0 million, and -$5.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -246.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 3.32 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 2.16 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -644.37 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 237.01 Mn |
| 10 | Cingulate | 72.81 Mn | 72.81 Mn | - | -4.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.64 Mn |
| Dec 31, 2025 | -4.95 Mn |
| Sep 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | -4.92 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -2.50 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Dec 31, 2023 | -5.48 Mn |
| Sep 30, 2023 | -4.72 Mn |
| Jun 30, 2023 | -5.23 Mn |
| Mar 31, 2023 | -3.16 Mn |
| Dec 31, 2022 | -3.63 Mn |
| Sep 30, 2022 | -3.18 Mn |
| Jun 30, 2022 | -3.19 Mn |
| Mar 31, 2022 | -3.96 Mn |
| Dec 31, 2021 | -2.65 Mn |
| Sep 30, 2021 | -15.29 Mn |
| Jun 30, 2021 | -1.43 Mn |
API Access
Cingulate Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();